Roundtable Discussion: Isaacs Discusses Second- and Third-Line Therapy for Patients with TNBC
March 21st 2022During a Targeted Oncology case-based roundtable event, Claudine Isaacs, MD, discussed treatment options for a patient with triple-negative breast cancer whose condition worsened after first-line gemcitabine plus carboplatin.